(818) 356-8248 info@theacrm.com

Macular Degeneration

Below is a sample of existing clinical evidence:
“Animals received syngeneic MSCs (1×106 cells) by tail vein at an age before major photoreceptor loss… both rod and cone photoreceptors were preserved (5–6 cells thick) at the time when control animal has a single layer of photoreceptors remained; Visual function was significantly preserved compared with controls… The number of pathological vascular complexes (abnormal vessels associated with migrating pigment epithelium cells) and area of vascular leakage that would ordinarily develop were dramatically reduced… There was an increase in neurotrophic factors within eyes of animals that received MSCs.”

-“Non-Invasive Stem Cell Therapy in a Rat Model for Retinal Degeneration and Vascular Pathology,” Wang et al, PLOS ONE, 2010

For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).

Visit AAICT